Skip to content

Inspection Record

Veterinary Pharmacy Corporation — FDA 483 Findings

US FDAInspected 2026-03-19Published 2026-10-22 3 findingsAseptic processing and sterility assuranceContamination controlDeviation, CAPA, and investigation

Inspectors Nicholas J Presto · Beatrix D Hippe · Vaishali J PatelThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Aseptic processing and sterility assurance

Failure to conduct media fills that closely simulate aseptic production operations under the worst-case, most-challenging, and stressful conditions.

2Contamination control

Contamination was observed in your production area and areas adjacent to production areas.

3Deviation, CAPA, and investigation

Deviation from the procedural requirements of a decree of injunction.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-10-22. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Other records for this company

Veterinary Pharmacy Corporation findings history — including this company's other documentsAll US FDA findings US FDA documents, 2026 Go to Findings search
Linked from (backlinks)
Briefs that featured this document
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.